Thierry Naas
Impact in
- Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.01%
- Vibrio bacteria research studies
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Antibiotic Resistance in Bacteria 332
- Endocrinology 152
- Vibrio bacteria research studies 61
- Infections and bacterial resistance 52
- Enterobacteriaceae and Cronobacter Research 46
- Co-authors
- Patrice Nordmann (143 shared papers)Laurent Poirel (42 shared papers)Gaëlle Cuzon (44 shared papers)Laurent Dortet (131 shared papers)Rémy A. Bonnin (106 shared papers)Delphine Girlich (77 shared papers)Youri Glupczynski (25 shared papers)Saoussen Oueslati (68 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (98 papers)Journal of Antimicrobial Chemotherapy (58 papers)International Journal of Antimicrobial Agents (21 papers)Journal of Clinical Microbiology (17 papers)Emerging infectious diseases (15 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Thierry Naas
388 papers receiving 23.8k citations
Thierry Naas's Hit Papers
Peers
Comparison fields: 5 of 167
- Molecular Medicine 18.1k
- Endocrinology 7.5k
- Applied Microbiology and Biotechnology 2.2k
- Clinical Biochemistry 2.9k
- Pollution 3.6k
Countries citing papers authored by Thierry Naas
This map shows the geographic impact of Thierry Naas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Naas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Naas more than expected).
Fields of papers citing papers by Thierry Naas
This network shows the impact of papers produced by Thierry Naas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Naas. The network helps show where Thierry Naas may publish in the future.
Co-authors
The 25 scholars most cited alongside Thierry Naas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 402 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global Spread of Carbapenemase-producing Enterobacteriaceae Hit paper breakdown → | 2011 | 1997 |
| 2 | The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria Hit paper breakdown → | 2009 | 1342 |
| 3 | High Frequency Retrotransposition in Cultured Mammalian Cells Hit paper breakdown → | 1996 | 833 |
| 4 | Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe Hit paper breakdown → | 2012 | 752 |
| 5 | Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial Hit paper breakdown → | 2020 | 678 |
| 6 | Diversity, Epidemiology, and Genetics of Class D β-Lactamases Hit paper breakdown → | 2009 | 546 |
| 7 | Beta-lactamase database (BLDB) – structure and function Hit paper breakdown → | 2017 | 523 |
| 8 | 2000 | 498 | |
| 9 | The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee Hit paper breakdown → | 2016 | 457 |
| 10 | 2008 | 431 | |
| 11 | 2009 | 384 | |
| 12 | 2000 | 375 | |
| 13 | 1997 | 366 | |
| 14 | 2010 | 272 | |
| 15 | Antimicrobial Peptides: A Potent Alternative to Antibiotics Hit paper breakdown → | 2021 | 264 |
| 16 | 2016 | 259 | |
| 17 | 2001 | 204 | |
| 18 | 1999 | 202 | |
| 19 | 2007 | 197 | |
| 20 | 1997 | 188 |
About Thierry Naas
Thierry Naas is a scholar working on Molecular Medicine, Endocrinology, Clinical Biochemistry, Pharmacology and Pollution, having authored 402 papers that have together received 24.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (332 papers), Bacterial biofilms and quorum sensing (70 papers), Vibrio bacteria research studies (61 papers), Bacterial Identification and Susceptibility Testing (56 papers), Antibiotics Pharmacokinetics and Efficacy (54 papers), Infections and bacterial resistance (52 papers), Enterobacteriaceae and Cronobacter Research (46 papers) and Pharmaceutical and Antibiotic Environmental Impacts (45 papers). The work is most often cited by research in Molecular Medicine (18.1k citations), Endocrinology (7.5k citations), Applied Microbiology and Biotechnology (2.2k citations), Clinical Biochemistry (2.9k citations) and Pollution (3.6k citations). Thierry Naas has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Patrice Nordmann, Laurent Poirel, Gaëlle Cuzon, Laurent Dortet, Rémy A. Bonnin, Delphine Girlich, Youri Glupczynski, Saoussen Oueslati, Samuel Bellais and Ralph J. DeBerardinis. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Journal of Clinical Microbiology and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.